What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Radiation therapy
Eric M. Horwitz spends much of his time researching Prostate cancer, Radiation therapy, Prostate, Internal medicine and Prostate-specific antigen.
His work carried out in the field of Prostate cancer brings together such families of science as Brachytherapy, Surgery, Nuclear medicine and Urology.
Eric M. Horwitz interconnects Stage and Clinical trial in the investigation of issues within Radiation therapy.
Eric M. Horwitz usually deals with Prostate and limits it to topics linked to Carcinoma and Tumor Oxygenation.
Many of his studies on Internal medicine apply to Oncology as well.
His research integrates issues of Predictive value of tests and Proportional hazards model in his study of Prostate-specific antigen.
His most cited work include:
- Prostate cancer. Clinical practice guidelines in oncology. (870 citations)
- Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02 (613 citations)
- Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology (544 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Prostate cancer, Internal medicine, Oncology, Radiation therapy and Prostate.
The concepts of his Prostate cancer study are interwoven with issues in Surgery, Brachytherapy and Urology.
His work in the fields of Internal medicine, such as Androgen deprivation therapy, Disease, Biochemical failure and Androgen, overlaps with other areas such as In patient.
His Oncology study integrates concerns from other disciplines, such as Androgen suppression, Randomized controlled trial, External beam radiation and Clinical trial.
Eric M. Horwitz has included themes like Multivariate analysis, Gynecology, Proportional hazards model and Nuclear medicine in his Radiation therapy study.
His studies deal with areas such as Radiation treatment planning, Biopsy, Radiology, Carcinoma and Perineural invasion as well as Prostate.
He most often published in these fields:
- Prostate cancer (67.24%)
- Internal medicine (51.08%)
- Oncology (46.12%)
What were the highlights of his more recent work (between 2016-2021)?
- Prostate cancer (67.24%)
- Internal medicine (51.08%)
- Oncology (46.12%)
In recent papers he was focusing on the following fields of study:
Eric M. Horwitz mainly focuses on Prostate cancer, Internal medicine, Oncology, Radiation therapy and Brachytherapy.
His Prostate cancer research is multidisciplinary, incorporating perspectives in Prostate, Radiology and Urology.
His study looks at the relationship between Urology and topics such as Bladder cancer, which overlap with Cisplatin.
His Oncology study also includes fields such as
- Randomized controlled trial that connect with fields like Clinical trial,
- Initial treatment together with Selection.
His Radiation therapy research is multidisciplinary, relying on both Prostate-specific antigen, Cohort and Hazard ratio.
The various areas that Eric M. Horwitz examines in his Brachytherapy study include Prostatectomy and Proportional hazards model.
Between 2016 and 2021, his most popular works were:
- Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology (544 citations)
- A War on Two Fronts: Cancer Care in the Time of COVID-19. (151 citations)
- Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. (135 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Radiation therapy
The scientist’s investigation covers issues in Prostate cancer, Internal medicine, Oncology, Radiation therapy and Cancer.
Eric M. Horwitz combines subjects such as Quality of life, Proportional hazards model, Brachytherapy and Urology with his study of Prostate cancer.
The study incorporates disciplines such as Dose fractionation, Prostate and Toxicity in addition to Urology.
His Internal medicine research is mostly focused on the topic Disease.
His work carried out in the field of Oncology brings together such families of science as Interquartile range and Randomized controlled trial.
The Radiation therapy study combines topics in areas such as Survival rate and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
